Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D08JRT
|
|||
| Former ID |
DCL000621
|
|||
| Drug Name |
RhApo2L/TRAIL
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Discontinued in Phase 1/2 | [1] | |
| Company |
Amgen
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800011860) | |||
| REF 2 | Clinical pipeline report, company report or official report of Amgen (2009). | |||
| REF 3 | ClinicalTrials.gov (NCT00508625) Amgen. Report of Amgen. July 2007. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.